Non-alcoholic steatohepatitis – a clinical case report

Authors

  • Nuno Devesa Médico do Internato Complementar de Medicina Interna, Serviço de Medicina II dos Hospitais da Universidade de Coimbra
  • Paulo Carrola Médico do Internato Complementar de Medicina Interna, Serviço de Medicina II dos Hospitais da Universidade de Coimbra
  • José Manuel Silva Professor Auxiliar de Medicina Interna da Faculdade de Medicina da Universidade de Coimbra
  • Mário Borges Alexandrino Chefe de Serviço de Medicina Interna, Serviço de Medicina II dos Hospitais da Universidade de Coimbra
  • José Júlio Alves de Moura Director de Serviço de Medicina II; Professor Associado da Faculdade de Medicina da Universidade de Coimbra

Keywords:

non-alcoholic steatohepatitis, obesity, diabetes

Abstract

The authors describe a clinical case of non-alcoholic steatohepatitis. In this patient’s
case there was clinical evolution to hepatic cirrhosis.
The authors present a review of this pathology.

Downloads

Download data is not yet available.

References

Laurin, J et al. Ursodeoxycholic acid or clofibrate in the treatment of nonalcoholic steatohepatitis: a pilot study. Hepatology 1996; 23(6): 1464-1467.

Marchesini, G et al. Metformin in nonalcoholic steatohepatitis. Lancet 2001; 358: 893-894.

Sheth, SG et al. Nonalcoholic steatohepatitis. Ann Inter Med 1997; 126: 137-145

Baldrige et al. Idiopatic steatohepatitis in childhood: a multicenter retrospective study. J. Pediatric 1995; 127(5): 700-704.

Rashid,M et al. Nonalcoholic steatohepatitis in children. J Pediatric Gastroenterol Nutr 2000; 30(1): 48-53.

Angulo, P et al. Independent predictors of liver fibrosis in patients with nonalcoholic steatoheptitis. Hepatology 1999; 30(6): 1356-1362.

Diehl, M et al. Nonalcoholic steatohepatitis. Seminar Liver Dis 1999; 19(2):221-229.

Kumar, KS et al. Nonalcoholic steatohepatitis. Mayo Clinic Proc 2000; 75(7): 733-739.

Neuschwander et al. Nonalcoholic steatohepatitis: an evolving diagnosis. Can J Gastro 2000; 14(4): 321-326.

Silva, PM et al. Nonalcoholic steatohepatitis. Acta Médica Port 1995; 8(5): 323-327.

Lucky, FH et al. Nonalcoholic steatohepatitis: association with obesity and insulin resistance and influence of weight loss. Diabetes Metab 2000; 26(2): 98-106.

Marceau,P et al. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab 1999; 84(5): 1513-1517.

Weltman, MD et al. Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology 1998; 27(1): 128-133.

Herbert, T et al. Mechanisms of disease: cytokines in alcoholic and nonalcoholic steatohepatitis. NEJM 2000; 343 (20): 1467-1476.

Sorbi, D et al. The ratio of AST to ALT: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver diseases. Am J Gastroenterol 1995; 94(4): 1018-1022.

Wanless, IR et al. Steatohepatitis and obesity: an autopsy study with analysis of risk factors. Hepatology 1990; 12: 1106-1110.

Weltman, MD et al. Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology 1998; 27(1): 128-133

Additional Files

Published

2002-09-30

How to Cite

1.
Devesa N, Carrola P, Silva JM, Borges Alexandrino M, Alves de Moura JJ. Non-alcoholic steatohepatitis – a clinical case report. RPMI [Internet]. 2002 Sep. 30 [cited 2024 Sep. 7];9(3). Available from: https://revista.spmi.pt/index.php/rpmi/article/view/1865

Issue

Vol. 9 No. 3 (2002): Julho/ Setembro

Section

Case Reports

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2023 Medicina Interna

Open Access

Most read articles by the same author(s)

1 2 > >>